OB, you are right they cut a lousy deal and now that a company that is committed to a line of CNS pharmaceuticals that now has bought Ovation, I suspect they will support that line strongly. That they had to buy the whole company with its prexisting obligations is not in question, its just once they own it, the GTCB connection may not be part of the company's long term goals a la LEO. Perhaps they pay a penalty or some such. UNLESS, they are looking to diversify in which case maybe they get the motherlode. Doubtful in my opinion. bp
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.